The Valley Desk

ReviewInternational journal of molecular sciencesPublished

GM1 Ganglioside as a Disease-Modifying Therapeutic for Parkinson's Disease: A Multi-Functional Glycosphingolipid That Targets Multiple Parkinson's Disease-Relevant Pathogenic Mechanisms

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Thomas Jefferson University. Affiliation source

Publication record

Type
Review
Venue
International journal of molecular sciences
Published
Subject terms
Humans; Parkinson Disease; Glycosphingolipids; Gangliosides; G(M1) Ganglioside; Parkinson’s Disease; Disease Modification; Gm1 Ganglioside
PubMed ID
37298133
PubMed Central ID
PMC10252733
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal